Alliancebernstein L.P. lessened its stake in Trupanion, Inc. (NASDAQ:TRUP – Free Report) by 7.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 37,597 shares of the financial services provider’s stock after selling 3,040 shares during the period. Alliancebernstein L.P. owned about 0.09% of Trupanion worth $1,812,000 at the end of the most recent reporting period.
A number of other hedge funds also recently modified their holdings of the company. Jones Financial Companies Lllp grew its holdings in shares of Trupanion by 71.7% during the fourth quarter. Jones Financial Companies Lllp now owns 570 shares of the financial services provider’s stock worth $27,000 after purchasing an additional 238 shares during the last quarter. GAMMA Investing LLC raised its position in shares of Trupanion by 18.5% during the fourth quarter. GAMMA Investing LLC now owns 1,709 shares of the financial services provider’s stock worth $82,000 after acquiring an additional 267 shares during the last quarter. SBI Securities Co. Ltd. bought a new stake in Trupanion during the 4th quarter worth about $25,000. Swiss National Bank lifted its position in Trupanion by 1.1% during the 4th quarter. Swiss National Bank now owns 66,310 shares of the financial services provider’s stock valued at $3,196,000 after purchasing an additional 700 shares during the period. Finally, JPMorgan Chase & Co. boosted its stake in Trupanion by 2.7% in the third quarter. JPMorgan Chase & Co. now owns 28,317 shares of the financial services provider’s stock valued at $1,189,000 after acquiring an additional 738 shares during the last quarter.
Analyst Upgrades and Downgrades
Several equities analysts have weighed in on TRUP shares. Stifel Nicolaus cut their target price on Trupanion from $44.00 to $41.00 and set a “hold” rating on the stock in a research note on Thursday, February 20th. Piper Sandler reduced their price target on shares of Trupanion from $57.00 to $52.00 and set an “overweight” rating for the company in a report on Thursday, February 20th. Two research analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, Trupanion has a consensus rating of “Moderate Buy” and an average target price of $46.60.
Insider Activity at Trupanion
In other news, SVP Emily Dreyer sold 14,025 shares of the business’s stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $32.41, for a total value of $454,550.25. Following the completion of the sale, the senior vice president now owns 27,645 shares of the company’s stock, valued at approximately $895,974.45. The trade was a 33.66 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Margaret Tooth sold 2,294 shares of the firm’s stock in a transaction that occurred on Tuesday, March 4th. The stock was sold at an average price of $31.39, for a total transaction of $72,008.66. Following the transaction, the chief executive officer now directly owns 118,784 shares in the company, valued at $3,728,629.76. This represents a 1.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 29,792 shares of company stock worth $989,442. Company insiders own 5.50% of the company’s stock.
Trupanion Stock Performance
Shares of TRUP stock opened at $34.72 on Friday. The company’s fifty day simple moving average is $36.92 and its 200-day simple moving average is $45.56. Trupanion, Inc. has a 12 month low of $19.69 and a 12 month high of $57.90. The company has a quick ratio of 1.66, a current ratio of 1.71 and a debt-to-equity ratio of 0.39. The firm has a market cap of $1.48 billion, a PE ratio of -150.96, a P/E/G ratio of 6.02 and a beta of 1.66.
Trupanion (NASDAQ:TRUP – Get Free Report) last announced its quarterly earnings data on Wednesday, February 19th. The financial services provider reported $0.04 EPS for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.02). Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.08%. The firm had revenue of $337.31 million during the quarter, compared to the consensus estimate of $335.41 million. Equities research analysts expect that Trupanion, Inc. will post 0.13 EPS for the current fiscal year.
Trupanion Profile
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Further Reading
- Five stocks we like better than Trupanion
- Stock Average Calculator
- Tariff Exemptions Set the Stage for a Taiwan Semiconductor Rally
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Mitigating Tariffs: 3 Stocks to Gain From a Weaker U.S. Dollar
- How to Calculate Stock Profit
- Broadcom’s Apple Relationship: AI Opportunity Meets Tariff Risk
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.